| Q39893157 | Acute Hepatitis B After the Implementation of Universal Vaccination in Italy: Results From 22 Years of Surveillance (1993-2014). |
| Q92549207 | Association between Body Mass Index and Hepatitis B antibody seropositivity in children |
| Q50683228 | Characteristics of immune memory 10-15 years after primary hepatitis B vaccination. |
| Q28077264 | Current preventive policies and practices against Vaccine-Preventable Diseases and tuberculosis targeted for workers from hospitals of the Sardinia Region, Italy |
| Q37135095 | Hepatitis B immune status in adolescents vaccinated during infancy: A retrospective cohort study from a pediatric practice in Germany |
| Q58721551 | Immune Persistence After Infant Hepatitis-B Vaccination: A Systematic Review and Meta-Analysis |
| Q28083219 | Immune response to Hepatitis B vaccine in patients with celiac disease: A systematic review and meta-analysis |
| Q55006232 | Impaired Immune Response to Primary but Not to Booster Vaccination Against Hepatitis B in Older Adults. |
| Q87802119 | Improving a process to obtain hepatitis B serology among patients treated with infliximab at a large urban children's hospital |
| Q47589860 | Is hepatitis B vaccination performed at infant and adolescent age able to provide long-term immunological memory? An observational study on healthcare students and workers in Florence, Italy |
| Q54678968 | Long-term Protection After Hepatitis B Vaccine. |
| Q54249328 | Long-term immunity to hepatitis B following vaccination in infancy: Real-world data analysis. |
| Q35887324 | Normal or defective immune response to Hepatitis B vaccine in patients with diabetes and celiac disease |
| Q64881036 | Persistence of Immunity for Hepatitis B Virus among Heathcare Workers and Italian Medical Students 20 Years after Vaccination. |
| Q50593538 | Persistence of immunity 18-19 years after vaccination against hepatitis B in 2 cohorts of vaccinees primed as infants or as adolescents in Italy. |
| Q54219752 | Persistence of immunity to hepatitis B vaccine as infants, 17 years earlier. |
| Q37669416 | Persistence of protective anti-HBs antibody levels and anamnestic response to HBV booster vaccination: A cross-sectional study among healthcare students 20 years following the universal immunization campaign in Italy |
| Q40042775 | Prevalence of anti-hepatitis B surface antibodies among children and adolescents vaccinated in infancy and effect of booster dose administered within a pilot study. |
| Q48103063 | Revaccination against hepatitis B in late teenagers who received vaccination during infancy: Yes or no? |
| Q38721154 | Safety and immune response to a challenge dose of hepatitis B vaccine in healthy children primed 10years earlier with hexavalent vaccines in a 3, 5, 11-month schedule: An open-label, controlled, multicentre trial in Italy. |
| Q47553145 | The effects of booster vaccination of hepatitis B vaccine on children 5-15 years after primary immunization: a 5-year follow-up study |
| Q35224155 | The long-term immunogenicity of recombinant hepatitis B virus (HBV) vaccine: contribution of universal HBV vaccination in Italy |
| Q99607731 | Variable anti-HBs antibody titers in vaccinated birth cohorts - A cross-sectional population-based study |